Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 26;19(3):173-81.
doi: 10.1016/j.rpor.2013.08.007. eCollection 2014 May.

Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis

Mohammed S Fayaz  1 , Mustafa S El-Sherify  1 , Amany El-Basmy  2 , Sadeq A Zlouf  1 , Nashwa Nazmy  1 , Thomas George  1 , Susan Samir  1 , Gerges Attia  1 , Heba Eissa  1
Affiliations

Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis

Mohammed S Fayaz et al. Rep Pract Oncol Radiother. .

Abstract

Aim: The aim of this study was to determine the incidence of TNBC in Kuwait, to analyze the clinicopathologic features and prognosis of this type of breast cancer, and compare it with reports from other regions of the world.

Background: Triple negative breast cancer (TNBC) is defined as a subtype that is negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). There is a growing evidence of the heterogeneity of such entity on the molecular level that may cause discrete outcomes.

Methods: We analyzed the clinicopathologic features of 363 TNBC cases which were diagnosed in Kuwait from July 1999 to June 2009. The disease-free survival (DFS) and overall survival (OS) were analyzed by Kaplan-Meier method. Comparison was done with reports from USA, Europe, Middle and Far East.

Results: Among 2986 patients diagnosed with breast cancer in Kuwait, 363 patients (12.2%) were TNBC. The median age was 48 years, 57.2% had lymph nodes (LN) metastasis, 56.9% were of grade III tumor and 41.9% had stage II disease. 81% developed recurrences and 75% of deaths occurred by 2.5 years after treatment. There is marked variation of clinicopathologic features according to country of patients' cohort.

Conclusion: The incidence of TNBC in our study is similar to other studies. TNBC patients showed an early major recurrence surge peaking at approximately year 2.5. Regional variation of clinicopathologic features indicates a need for molecular studies to define underlying molecular features and its impact on survival.

Keywords: Breast cancer; Clinicopathological; Epidemiology; Triple negative; Variation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
DFS and OS of all study cohor (cumulative and by stage).
See this image and copyright information in PMC

References

    1. Glass A.G., Lacey J.V., Jr., Carreon J.D. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99:1152–1161. - PubMed
    1. Early Breast Cancer Trialists’ Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717. - PubMed
    1. Goldhirsch A., Wood W.C., Gelber R.D. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133–1144. - PubMed
    1. Piccart-Gebhart M.J., Procter M., Leyland-Jones B. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659–1672. - PubMed
    1. Romond E.H., Perez E.A., Bryant J. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673–1684. - PubMed